AI Signal & Stock Analysis · Avoid ↓
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for MDGL is Avoid ↓; the stock is at $504.56 (-0.55% today); neutral (RSI 45); technical trend is down-trend; news sentiment is nan.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Avoid ↓ |
|---|---|
| Price | $504.56 |
| Change today | -0.55% |
| RSI (14) | 45.05 |
| Relative volume | 0.46 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $11.7B |
| Forward P/E | 77.02 |
| 52-week high | -17.9% away |
| 52-week low | +43.6% above |
| Technical trend | Down-trend (since 2026-05-28) |
| News sentiment | Nan |
| Sector | Healthcare-Biotech |
| Next earnings | 7/30/2026 8:30:00 AM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns MDGL (Madrigal Pharmaceuticals Inc) a Avoid signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
MDGL's RSI is neutral (RSI 45). A reading above 70 is typically considered overbought and below 30 oversold.
MDGL is trading about 18% below its 52-week high and 44% above its 52-week low as of Aug 14 2026, 1:04 PM.
MDGL's next earnings date is 7/30/2026 8:30:00 AM.
MDGL is classified under Healthcare-Biotech in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.